Abstract: According to the present invention there is provided composition in the form of an oil-in-water emulsion having a viscosity of between 15,000 cP (15 Pa-s) and 45,000 cP (45 Pa-s) at 23° C., having a pH of between 2 and 6 and comprising: (i) at least 1.6 wt. % of at least one cross-linked anionic polyelectrolyte resulting from the polymerisation of partially or completely salified 2-methyl 2-[(1-oxo 2-propenyl)amino]1-propane sulfonic acid, with at least one neutral monomer chosen from the N,N-dialkyl acrylamides, wherein each of the alkyl groups comprises between one and four carbon atoms, and at least one monomer of formula (B): wherein R represents a linear or branched alkyl radical comprising eight to twenty carbon atoms and n represents a number greater than or equal to one and less than or equal to twenty, in the presence of at least one cross-linking agent; (ii) at least 4 wt. % of at least one polysorbate; (iii) at least 0.1 wt. % of at least one polysaccharide gum; and (iv) between 6 wt. % and 30 wt.

Abstract: According to the present invention there is provided a cosmetic composition comprising: (i) a polyphenolic antioxidant agent; and (ii) a sphingosine compound.

Abstract: According to the present invention there is provided a cosmetic composition comprising a cosmetically acceptable carrier and a surfactant system consisting of: (i) an anionic surfactant; (ii) an amphoteric surfactant; and (iii) a non-ionic surfactant, wherein the anionic surfactant is present in an amount of from about 0.5% to about 25% by weight of the surfactant system, wherein the amphoteric surfactant is present in an amount of from about 0.5% to about 50% by weight of the surfactant system, wherein the non-ionic surfactant is present in an amount of from about 0.5% to about 45% (e.g. 43%) by weight of the surfactant system, and wherein the total amount of the surfactant system present in the cosmetic composition is from about 1.5% to about 25% by weight of the composition.

Abstract: According to the present invention there is provided a cosmetic composition comprising: (i) a salicylic acid compound; (ii) monoammonium glycyrrhizate; and (iii) a polyphenolic antioxidant agent.

Abstract: The disclosed technology relates to a composition comprising: 0.1 to 3 wt % (or 0.5 to 2.5 wt %) of a beta hydroxy acid, 0.05 to 3 wt % (or 0.09 to 2.5 wt %) of an O-substituted ascorbic acid or a derivative thereof, and a cosmetically acceptable medium comprising an aqueous phase, wherein a beta hydroxy acid is present at a higher concentration than O-substituted ascorbic acid or a derivative thereof. The disclosed technology further relates to the use and method of improving skin condition.

Abstract: According to the present invention there is provided an aqueous concentrated cosmetic composition comprising at least 20% water, at least 4.5% by weight of the composition of humectant, at least 8% of the composition of a peptide and high levels of a skin benefit active(s).

Abstract: A soccer shoe absorbs and stores energy from the foot at foot-strike and return some of this energy to the object being struck. The shoe may also cushion the foot, leg and body; provide foot stability and motion control; reduce fatigue; extend the float time of a runner and increase the jump height of the wearer. The shoe is intended to absorb, store and return energy to the object struck, which would otherwise be lost using the existing shoe components and inserts. The shoe has a vertical component that extends around the periphery of the front of the shoe and another component (horizontal) that extends longitudinally from the front of the shoe towards the back of the shoe, at least to about the middle of the shoe, and preferably proximate the heel of the shoe.

Abstract: The disclosed technology relates to a composition comprising: 0.1 to 3 wt % (or 0.5 to 2.5 wt %) of a beta hydroxy acid, 0.05 to 3 wt % (or 0.09 to 2.5 wt %) of an O-substituted ascorbic acid or a derivative thereof, and a cosmetically acceptable medium comprising an aqueous phase, wherein a beta hydroxy acid is present at a higher concentration than O-substituted ascorbic acid or a derivative thereof. The disclosed technology further relates to the use and method of improving skin condition.

Abstract: A soccer shoe absorbs and stores energy from the foot at foot-strike and return some of this energy to the object being struck. The shoe may also cushion the foot, leg and body; provide foot stability and motion control; reduce fatigue; extend the float time of a runner and increase the jump height of the wearer. The shoe is intended to absorb, store and return energy to the object struck, which would otherwise be lost using the existing shoe components and inserts. The shoe has a vertical component that extends around the periphery of the front of the shoe and another component (horizontal) that extends longitudinally from the front of the shoe towards the back of the shoe, at least to about the middle of the shoe, and preferably proximate the heel of the shoe.

Abstract: A water-in-oil emulsion comprising less than 60% water, and wherein said emulsion comprises an oil phase and a water phase, and wherein the water phase comprises a dipeptide selected from the group consisting of acetyl dipeptide (1) cetyl ester, acetyl dipeptide (3) aminohexanoate, azelaoyl bisdipeptide (10), coumaroyl dipeptide (3), dicetyl dipeptide (9), dipeptide diamino butyroyl benzylamide diacetate, dipeptide (1), dipeptide (10), dipeptide (11), dipeptide (12), dipeptide (15), dipeptide (16), dipeptide (17), dipeptide (18), dipeptide (19), dipeptide (2), dipeptide (20), dipeptide (3), dipeptide (4), dipeptide (5), dipeptide (6), dipeptide (7), dipeptide (8), dipeptide (8) HCL, dipeptide (9), hexanoyl dipeptide (3) norleucine acetate, methyl undecylenoyl dipeptide (16), nicotinoyl dipeptide (22), nicotinoyl dipeptide (23), nicotinoyl dipeptide (24), nicotinoyl dipeptide (26), oleoyl dipeptide (15), palmitoyl dipeptide (10), palmitoyl dipeptide (13), palmitoyl dipeptidel (7), palmitoyl dipeptide (5) diami

Abstract: The present invention relates to footwear and in particular, but not necessarily restricted thereto, relates to footwear for those with diabetes and, in particular, with ulcers of the sole. The present invention seeks to address some of the problems encountered by prior art limb compression devices and methods. In particular the present invention seeks to provide a boot which can stimulate blood flow. A further object to the invention is to provide a boot with a sole which is adaptable to conform with various shapes and conditions of human feet. The present invention also seeks to provide a new type of footwear that has a therapeutic benefit for diabetic patients with circulatory problems in their foot, and also enables the technique of “off loading” the foot to assist in the healing of any wounds present.

Abstract: A water-in-oil emulsion comprising less than 60% water, and wherein said emulsion comprises an oil phase and a water phase, and wherein the water phase comprises a dipeptide selected from the group consisting of acetyl dipeptide (1) cetyl ester, acetyl dipeptide (3) aminohexanoate, azelaoyl bisdipeptide (10), coumaroyl dipeptide (3), dicetyl dipeptide (9), dipeptide diamino butyroyl benzylamide diacetate, dipeptide (1), dipeptide (10), dipeptide (11), dipeptide (12), dipeptide (15), dipeptide (16), dipeptide (17), dipeptide (18), dipeptide (19), dipeptide (2), dipeptide (20), dipeptide (3), dipeptide (4), dipeptide (5), dipeptide (6), dipeptide (7), dipeptide (8), dipeptide (8) HCL, dipeptide (9), hexanoyl dipeptide (3) norleucine acetate, methyl undecylenoyl dipeptide (16), nicotinoyl dipeptide (22), nicotinoyl dipeptide (23), nicotinoyl dipeptide (24), nicotinoyl dipeptide (26), oleoyl dipeptide (15), palmitoyl dipeptide (10), palmitoyl dipeptide (13), palmitoyl dipeptidel (7), palmitoyl dipeptide (5) diami